http://www.bloomberg.com/news/articles/2016-03-22/ackman-said-to-address-valeant-workers-side-by-side-with-pearson Update your resume folks.
http://www.reuters.com/article/us-valeant-ceo-idUSKCN0YE1LT Papa told investors at the UBS Global Healthcare Conference that the company would fund the payoffs in part through the sale of non-core assets outside of its main franchises if it can get attractive prices for the assets. Papa said core assets include the dermatology business, Bausch & Lomb eyecare, and its gastroenterology products, many of which were acquired in its purchase of Salix Pharmaceuticals last year. ...No mention of ECR being a core asset folks. We have six months max.
